Policy guides
Plain-language guides place legislative proposals, regulatory terms, and implementation questions in sequence. They are designed to distinguish what a proposal says from what it does not yet change.
Civic Mycelium / Information services
Services
Guides, comparisons, and research summaries for people working through IBOGAINE Act questions with context, care, and attention to policy limits.
A clear starting point
Information for difficult questions.
Civic Mycelium is an independent resource on the IBOGAINE Act, ibogaine policy, research, and access questions. It helps veterans, families, advocates, and policymakers navigate complex information with context and care.
These offerings are informational: they organize public policy, research, terminology, and access questions without substituting for medical or legal advice. The IBOGAINE Act resource provides the wider context for this work, while our approach to independence and sourcing explains the principles behind it.
What we organize
A practical library, built for careful reading.
Condition-specific context
Comparisons help readers separate policy discussion from condition-specific claims, including questions raised in dementia-focused ibogaine discussions and Alzheimer’s-related information.
Research summaries
Evidence summaries identify the difference between early research, reported experience, and established care. Ibogaine is a naturally occurring psychoactive alkaloid, and its legal and clinical context requires careful interpretation.
Decision frameworks
Structured question sets support families, advocates, and policymakers who are sorting through safety, oversight, and access. For trauma-specific context, readers may compare the framing in trauma and ibogaine materials.
Comparison without shortcuts
Evidence is not a promise.
Glossary and definitions
Shared definitions can make policy conversations more useful. Our materials clarify common terminology before comparing claims, including questions related to concussions and ibogaine.
Safety-aware access context
Access questions need clear boundaries. The U.S. Drug Enforcement Administration maintains a public explanation of drug scheduling, a useful starting point for understanding why legal status and treatment claims cannot be treated as the same issue.
Questions for supervised settings
When readers encounter claims about oversight, the focus should remain on what is verifiable and what risks are acknowledged. The material at supervised ibogaine information can be read alongside these broader policy questions, not as a substitute for professional care.
“Independence, plain language, evidence first, safety awareness, and policy clarity guide how this resource organizes complex information.”
Frequently asked questions
What these services are—and are not.
Are these clinical services?
No. Civic Mycelium provides information, guides, comparisons, research summaries, and question frameworks. It does not provide diagnosis, treatment, referrals, or clinical care.
Can the material identify a local provider?
No directory should replace due diligence or professional advice. Readers assessing location-based claims may encounter ibogaine clinic location information, but should independently verify legal status, qualifications, safety practices, and applicable requirements.
Who are these guides for?
The material is intended for veterans, families, advocates, policymakers, and others seeking grounded information about ibogaine and related U.S. policy. It is written to make uncertainty visible rather than to promise an outcome.
Keep the distinctions clear
Policy questions deserve more than a simple answer.
Use these information services to compare sources, define terms, and understand the limits of what public evidence and policy language can establish.
If you need a fuller view of the organization behind this work, visit Civic Mycelium’s mission and editorial principles.